Study to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive Disorder
Clinical trial NCT01725282 · COMPLETED
Trial details
- NCT number
- NCT01725282
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-14
- Primary completion
- 2013-08-24
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.